Navigation Links
Tengion to Host Conference Call to Provide a Business Update and Report First Quarter 2011 Financial Results on May 12, 2011
Date:5/4/2011

EAST NORRITON, Pa., May 4, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Thursday, May 12, 2011 at 8:30 a.m. EDT to provide a business update and discuss its first quarter 2011 financial results.  

To participate in the call, please dial 1-866-383-7989 (domestic) or 1-617-597-5328 (international) and reference access code 64874944.

This conference call will also be webcast live and can be accessed from the Investors section of the Company's website at http://www.tengion.com or at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=218965&eventID=4014467.  The webcast will be archived on the website until June 12, 2011.  

About Tengion

Tengion, a clinical-stage biotechnology company, has pioneered the Organ Regeneration Platform™ that enables the Company to create proprietary product candidates that are intended to harness the intrinsic regenerative pathways of the body to produce a range of native-like organs and tissues. Tengion's product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. An initial clinical trial is ongoing for the Company's lead product candidate, the Neo-Urinary Conduit™, an autologous implant that is intended to catalyze regeneration of native-like bladder tissue for bladder cancer patients requiring a urinary diversion following bladder removal. The Company's lead preclinical program is the Neo-Kidney Augment™, which is designed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure. Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment™ for the treatment of neurogenic bladder. Tengion has worldwide rights to its product candidates. For more information, please visit www.tengion.com.


'/>"/>
SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
2. Tengion To Host Conference Call To Provide a Business Update and Report Fourth Quarter 2010 Financial Results on March 25, 2011
3. Tengion Announces Pricing of $31.4 Million Private Placement
4. Tengion Addresses Recent Trading Activity in its Common Stock
5. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
6. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
7. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
8. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
9. Tengion Appoints A. Brian Davis Chief Financial Officer
10. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
11. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Feb. 12, 2016  BD (Becton, Dickinson and Company) ... company, today announced the launch of the BD CLiC™ ... Technology (AGBT) Meeting. --> ... research by providing cost effective NGS library preparation with ... high-throughput, fully integrated, next generation sequencing (NGS) library prep ...
(Date:2/12/2016)... Feb. 12, 2016  PTC Therapeutics, Inc. (NASDAQ: ... STRIVE (Strategies to Realize Innovation, Vision and Empowerment) ... STRIVE provides funds to patient advocacy organizations to ... meaningful contributions to the rare disease community by ... future patient advocates. Mary Frances ...
(Date:2/12/2016)... FRANCISCO , February 12, 2016 ... Medicine Efforts by Enabling Scientific Understanding of Complex ... and Rare Diseases --> ... genomic diagnostics in South Asia and a leading provider ... would contribute $10 million to the GenomeAsia 100K ...
(Date:2/11/2016)... ORLANDO, Florida , February 11, 2016 ... Populations and Promote Genetic Understanding to Support Research and Discovery ... consortium, GenomeAsia 100K, today announced an ambitious plan to sequence ... 12 South Asian countries and at least 7 of North ... --> In the first phase, the project will focus ...
Breaking Biology Technology:
(Date:2/11/2016)...  According to new research from Acuity Market ... 200 fingerprint, iris, and eye-vein biometric smartphones have ... names. This includes market leaders Apple, Samsung, Huawei, ... that 600 million biometric smartphones are currently in ... Maxine Most , Acuity Market Intelligence ...
(Date:2/11/2016)... Solutions announces today that its license plate recognition (LPR) cameras ... Lee,s Summit Police Department to improve safety for ... homicide suspect. Kansas City , ... and is home to roughly 100,000 residents. Lee,s ... plate reader system and also leverages Vigilant,s network of commercially ...
(Date:2/10/2016)... February 10, 2016 ... to 2016 iris recognition market report, combined ... is more widely accepted for border control. ... fingerprint and iris recognition technology in a ... avoid purchasing two individual biometrics devices. ...
Breaking Biology News(10 mins):